IL-22 promotes intestinal health by regulating the function of intestinal epithelial cells and inhibiting lipid absorption, thus alleviating metabolic disorders associated with obesity to a certain extent (136). The gene discussed is IL22; the disease is obesity due to melanocortin 4 receptor deficiency.